Position in A
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$74,567,441
+$10,924,429 QoQ
Shares Held
561,375
+0.5% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
1.60%
of 13F equity value
Holder Rank
#77
of 1,112 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Fenimore Asset Management Inc holds $77,630,750 across 2 Diagnostics & Research names. A ranks #1 (96.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
This page
|
561,375 | $74,567,441 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
6,110 | $3,063,309 |
All Filings in A
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,567,441 | 561,375 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $63,643,012 | 558,370 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $80,957,840 | 594,972 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $75,277,275 | 586,500 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $21,345,648 | 180,880 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $20,595,147 | 176,057 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $24,110,402 | 179,473 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $26,291,947 | 177,074 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,536,823 | 173,855 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $25,221,830 | 173,334 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $23,666,381 | 170,225 | Shares | Sole | 2024-01-23 | |
| No filing history on record for this holder in this stock. | ||||||